These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 14715181)
1. Filling the need for new antiarrhythmic drugs to prevent shocks from implantable cardioverter defibrillators. Curtis AB J Am Coll Cardiol; 2004 Jan; 43(1):44-6. PubMed ID: 14715181 [No Abstract] [Full Text] [Related]
2. Ventricular arrhythmias in patients with implanted cardioverter defibrillators. John RM; Stevenson WG Trends Cardiovasc Med; 2012 Oct; 22(7):169-73. PubMed ID: 22902094 [TBL] [Abstract][Full Text] [Related]
3. Celivarone in patients with an implantable cardioverter-defibrillator: adjunctive therapy for the reduction of ventricular arrhythmia-triggered implantable cardioverter-defibrillator interventions. Gojkovic O; Aliot EM; Capucci A; Connolly SJ; Crijns H; Hohnloser SH; Kulakowski P; Roy D; Radzik D; Singh BN; Kowey PR Heart Rhythm; 2012 Feb; 9(2):217-224.e2. PubMed ID: 21978965 [TBL] [Abstract][Full Text] [Related]
4. [Electrical storm in ICD patients: prevention and treatment]. Zarse M; Bogossian H; Lemke B Herzschrittmacherther Elektrophysiol; 2014 Jun; 25(2):66-72. PubMed ID: 24823469 [TBL] [Abstract][Full Text] [Related]
5. Interactions of antiarrhythmic drugs and implantable devices in controlling ventricular tachycardia and fibrillation. Rajawat YS; Dias D; Gerstenfeld EP; Dixit S; Shah B; Russo AM; Marchlinski FE Curr Cardiol Rep; 2002 Sep; 4(5):434-40. PubMed ID: 12169241 [TBL] [Abstract][Full Text] [Related]
6. Antiarrhythmic drugs or implantable cardioverter defibrillators in heart failure: the "poor heart". Böcker D; Breithardt G Am J Cardiol; 1999 Mar; 83(5B):83D-87D. PubMed ID: 10089846 [TBL] [Abstract][Full Text] [Related]
8. Effects of flecainide therapy on inappropriate shocks and arrhythmias in catecholaminergic polymorphic ventricular tachycardia. Jacquemart C; Ould Abderrahmane F; Massin MM J Electrocardiol; 2012; 45(6):736-8. PubMed ID: 22672791 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE study. Kowey PR; Crijns HJ; Aliot EM; Capucci A; Kulakowski P; Radzik D; Roy D; Connolly SJ; Hohnloser SH; Circulation; 2011 Dec; 124(24):2649-60. PubMed ID: 22082672 [TBL] [Abstract][Full Text] [Related]
10. Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators. Bollmann A; Husser D; Cannom DS Am J Cardiovasc Drugs; 2005; 5(6):371-8. PubMed ID: 16259525 [TBL] [Abstract][Full Text] [Related]
11. Empiric antiarrhythmic drug therapy in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia: pragmatism or anachronism? Mitchell LB J Am Coll Cardiol; 2009 Aug; 54(7):616-7. PubMed ID: 19660691 [No Abstract] [Full Text] [Related]
12. Efficacy of antiarrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: a report from the North American ARVC Registry. Marcus GM; Glidden DV; Polonsky B; Zareba W; Smith LM; Cannom DS; Estes NA; Marcus F; Scheinman MM; J Am Coll Cardiol; 2009 Aug; 54(7):609-15. PubMed ID: 19660690 [TBL] [Abstract][Full Text] [Related]
14. Implantable cardioverter defibrillator therapy and the need for concomitant antiarrhythmic drugs. Singh S; Murawski MM J Cardiovasc Pharmacol Ther; 2007 Sep; 12(3):175-80. PubMed ID: 17875944 [TBL] [Abstract][Full Text] [Related]
15. Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia ablation versus drugs for preventing ICD shocks: role of adjuvant antiarrhythmic drug therapy. Patel C; Yan GX; Kocovic D; Kowey PR Circ Arrhythm Electrophysiol; 2009 Dec; 2(6):705-11; discussion 712. PubMed ID: 20009081 [No Abstract] [Full Text] [Related]
16. Antiarrhythmic drug use in the implantable defibrillator arm of the Antiarrhythmics Versus Implantable Defibrillators (AVID) Study. Steinberg JS; Martins J; Sadanandan S; Goldner B; Menchavez E; Domanski M; Russo A; Tullo N; Hallstrom A; Am Heart J; 2001 Sep; 142(3):520-9. PubMed ID: 11526368 [TBL] [Abstract][Full Text] [Related]
17. Recurrence of ventricular tachycardia degeneration by low-energy implantable cardioverter-defibrillator shocks: a case report. Cagli KE; Guray U; Akpinar I; Sen N; Aras D; Topaloglu S J Electrocardiol; 2010; 43(1):68-70. PubMed ID: 19446839 [TBL] [Abstract][Full Text] [Related]
18. Are implantable cardioverter-defibrillators better than conventional antiarrhythmic drugs for survivors of cardiac arrest? Zipes DP Circulation; 1995 Apr; 91(8):2115-7. PubMed ID: 7697837 [No Abstract] [Full Text] [Related]
19. Is there a role for antiarrhythmic drugs in patients with implantable defibrillators? Ho A; Assadi R; Pai SM; Pai RG Curr Cardiol Rep; 2006 Sep; 8(5):365-9. PubMed ID: 16956452 [TBL] [Abstract][Full Text] [Related]
20. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators N Engl J Med; 1997 Nov; 337(22):1576-83. PubMed ID: 9411221 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]